An exclusive report reveals that a couple paid over $800,000 for an experimental gene-editing therapy for their daughter, who subsequently died, despite the trial never being made public. This case highlights severe ethical breaches and lack of transparency in early-stage CRISPR-based medical treatments conducted in China.
Background
The article discusses a controversial and non-publicized gene-editing trial involving CRISPR technology, raising concerns about patient safety and regulatory oversight in experimental therapies.
- Source
- Hacker News (RSS)
- Published
- Jul 24, 2026 at 04:52 AM
- Score
- 9.0 / 10